New molecular scaffolds for the design of Alzheimer’s acetylcholinesterase inhibitors identified using ligand- and receptor-based virtual screening

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Medicinal Chemistry Research

• Publication date

  2013-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00044-012-0227-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• proteins STRUCTURE O FUNCTION O BIOINFORMATICS Protonate3D: Assignment of ionization

  2013cited by this paper
• Targeting the epidermal growth factor receptor: exploring the potential of novel inhibitor N-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy) quinolin- 4-amine using docking and molecular dynamics simulation.

  2012cited by this paper
• Identification of novel potent inhibitors against Bcl-xL anti-apoptotic protein using docking studies.

  2012cited by this paper
• Prediction of a new surface binding pocket and evaluation of inhibitors against huntingtin interacting protein 14: an insight using docking studies

  2011cited by this paper
• Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock

  2009cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009influential reference
• Structure tridimensionnelle de la butyrylcholinestérase humaine

  2008cited by this paper
• y-Randomization and Its Variants in QSPR/QSAR

  2007cited by this paper
• Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.

  2005cited by this paper
• Structure tridimensionnelle de la butyrylcholinestérase humaine :: Hypothèses mécanistiques et ingéniérie de mutéines dégradant les composés organophosphorés

  2005cited by this paper
• Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.

  2005cited by this paper
• LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters

  2005influential reference
• Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology.

  2005cited by this paper
• Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors.

  2005influential reference
• Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.

  2005cited by this paper
• Molecular modelling approaches to the design of acetylcholinesterase inhibitors: new challenges for the treatment of Alzheimer's disease.

  2004cited by this paper
• Acetylcholinesterase inhibition in Alzheimer's Disease.

  2004cited by this paper
• UCSF Chimera—A visualization system for exploratory research and analysis

  2004cited by this paper
• Alzheimer's disease pathogenesis and therapeutic interventions.

  2004cited by this paper
• Development of bivalent acetylcholinesterase inhibitors as potential therapeutic drugs for Alzheimer's disease.

  2004influential reference
• beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.

  2003cited by this paper
• Treatment of Alzheimer's disease: current status and new perspectives.

  2003cited by this paper
• Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.

  2003cited by this paper
• A new genetic algorithm with Lamarckian individual learning for generation scheduling

  2003influential reference
• Molecular properties that influence the oral bioavailability of drug candidates.

  2002cited by this paper
• Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine.

  2002cited by this paper
• Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit

  2002cited by this paper
• Acetylcholinesterase — new roles for an old actor

  2001cited by this paper
• A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase

  2001cited by this paper
• Treatment of Alzheimer's disease.

  2001cited by this paper
• Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation.

  2000cited by this paper
• Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors.

  2000cited by this paper
• Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.

  2000cited by this paper
• The cholinergic hypothesis of Alzheimer’s disease: a review of progress

  1999cited by this paper
• Structure of acetylcholinesterase complexed with (−)‐galanthamine at 2.3 Å resolution

  1999cited by this paper
• Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.

  1999influential reference
• Static Laue diffraction studies on acetylcholinesterase.

  1998cited by this paper
• Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.

  1998cited by this paper
• Virtual screening : an overview

  1998cited by this paper
• Structure of acetylcholinesterase complexed with the nootropic alkaloid, (–)-huperzine A

  1997influential reference
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

  1996cited by this paper
• The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase.

  1996cited by this paper
• An introduction to multivariate adaptive regression splines

  1995cited by this paper
• Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.

  1994influential reference
• Treatment for Alzheimer's disease?

  1992cited by this paper
• Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

  1985influential reference
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961influential reference
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper

• Computational design and in vitro assay of lantadene-based novel inhibitors of NS3 protease of dengue virus

  2024cites this paper
• Evaluation of Amaryllidaceae alkaloids as inhibitors of human acetylcholinesterase by QSAR analysis and molecular docking

  2021cites this paper
• Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies

  2021cites this paper
• Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors

  2021cites this paper
• Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation

  2021influential citation
• Computational refinement identifies functional destructive single nucleotide polymorphisms associated with human retinoid X receptor gene

  2021influential citation
• Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors

  2020cites this paper
• Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates

  2020cites this paper
• Molecular docking, dynamics, and pharmacology studies on bexarotene as an agonist of ligand‐activated transcription factors, retinoid X receptors

  2019cites this paper
• Computational Studies on Acetylcholinesterase Inhibitors: from Biochemistry to Chemistry.

  2019cites this paper
• Synthesis, characterization and investigation of AChE and BuChE inhibitory activity of 1-alkyl-4-[(5,6-dimethoxy-1-indanone-2-yl)methylene]pyridinium halide derivatives

  2019cites this paper
• Identification of New Potent Acetylcholinesterase Inhibitors Using Virtual Screening and in vitro Approaches

  2019cites this paper
• PURE CHEMICAL COMPOUNDS OBTAINED FROM TANZANIAN MEDICINAL PLANTS COMPETITIVELY BLOCK ATP BINDING IN DNA GYRASE AS ANTIMICROBIAL TARGET

  2018cites this paper
• Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge

  2018cites this paper
• Molecular interaction and inhibitory potential of selected plant-derived polyphenolic compounds with Human α-amylase

  2018cites this paper
• Eugenol sübstitüe yeni karbamat türevlerinin sentezi ve kolinesteraz enzimlerinin inhibisyonu

  2017cites this paper
• Arylidene indanone scaffold: medicinal chemistry and structure–activity relationship view

  2017cites this paper
• Synthesis, anticholinesterase activity and molecular modeling study of novel carbamate-substituted thymol/carvacrol derivatives.

  2017cites this paper
• Molecular Interaction and Inhibitory Potential of Polyphenol on DNA Repair Pathway in Small Cell Lung Cancer: A Computational Study

  2017cites this paper
• Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening

  2017cites this paper
• An Insight into the Precise Molecular Interaction and Inhibitory Potential of Amentoflavone and Its Substituted Derivatives on Human α-amylase

  2017cites this paper
• Computational analysis unravels novel destructive single nucleotide polymorphisms in the non-synonymous region of human caveolin gene

  2017cites this paper
• Toward a hierarchical virtual screening and toxicity risk analysis for identifying novel CA XII inhibitors

  2017cites this paper
• Molecular docking and molecular dynamics simulation approaches for identifying new lead compounds as potential AChE inhibitors

  2017cites this paper
• Molecular determinants and interaction data of cyclic peptide inhibitor with the extracellular domain of TrkB receptor

  2016cites this paper
• Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.

  2015cites this paper
• Bio/chemoinformatics in India: an outlook

  2015cites this paper
• Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives.

  2015cites this paper
• Exploring the Molecular Interactions of 7,8-Dihydroxyflavone and Its Derivatives with TrkB and VEGFR2 Proteins

  2015influential citation
• Design, Synthesis, and Evaluation of 7H‐thiazolo‐[3,2‐b]‐1,2,4‐triazin‐7‐one Derivatives as Dual Binding Site Acetylcholinesterase Inhibitors

  2014cites this paper
• Design and synthesis of tacrine-phenothiazine hybrids as multitarget drugs for Alzheimer’s disease

  2014cites this paper
• Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesterase

  2014cites this paper
• Bio/chemoinformatics in India: an

  2014cites this paper
• Salt marsh plants as source of bioactive compounds

  2014cites this paper
• Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents

  2014cites this paper
• Design, Synthesis, and Biological Evaluation of 7H-Thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives as Dual Binding Site Acetylcholinesterase Inhibitors

  2013cites this paper